CFTR modulators response of S737F and T465N CFTR variants on patient-derived rectal organoids
Abstract Background Predictions based on patient-derived materials of CFTR modulators efficacy have been performed lately in patient-derived cells, extending FDA-approved drugs for CF patients harboring rare variants. Here we developed intestinal organoids from subjects carrying S737F- and T465N-CFT...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMC
2024-09-01
|
| Cyfres: | Orphanet Journal of Rare Diseases |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1186/s13023-024-03334-3 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
